Ex-Dendreon chief Mitch Gold steers his way back to the public markets, looking to jumpstart a new clinical program
Mitch Gold is coming back to the helm of a public biotech company.
The former Dendreon CEO — and current venture capitalist — who was forced …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
